R. Brendan Fee

Brendan has been recognized on the Law360 Rising Stars list as one of the top five antitrust lawyers in the US and Europe under the age of 40 and was identified by Global Competition Review in its GCR 100 as a leading Pennsylvania antitrust practitioner. He also has been named a "Lawyer on the Fast Track" by The Legal Intelligencer, which recognizes Philadelphia lawyers under 40 who have demonstrated a commitment to legal excellence and community service.

Brendan has obtained dismissals and favorable settlements in class action and single-plaintiff cases involving alleged price fixing, exclusive dealing, monopolization, group boycotts, price discrimination, tying, bundling, and violations of state antitrust law. His clients in these cases are some of the top companies in a number of diverse industries such as pharmaceuticals, technology, healthcare, financial services, automotive, energy, and industrial products.

Brendan has written articles on vertical restraints and pricing, as well as antitrust issues in the life sciences industry. He also speaks on cutting-edge competition issues such as vertical restraints in e-commerce. In addition, Brendan has held leadership positions in the ABA Section of Antitrust Law, including most recently serving as young lawyer vice chair of the Section’s unilateral conduct committee.

As an adjunct professor of law at Rutgers Law School, Brendan teaches courses on topics such as legal writing and appellate advocacy. He is the litigation practice training partner for Morgan Lewis’s Philadelphia, Princeton, and Wilmington offices. He also participates in the firm’s Class Action Working Group.

Brendan's representative antitrust litigation successes include:

• Cable Line v. Comcast (M.D. Pa.) – Obtained dismissal on a Rule 12 motion of allegations of conspiracy to restrain trade in alleged cable installation market.
  
• In re North Sea Brent Crude Oil Futures Litigation (S.D.N.Y.) – Obtained dismissal of Section 1 and 2 Sherman Act claims arising out of alleged manipulation of benchmark for North Sea Brent Crude Oil.
  
• Medical Diagnostic Labs v. Indepdendence Blue Cross  (E.D. Pa.) – Secured dismissal of exclusive dealing antitrust claims concerning certain diagnostic tests on a motion to dismiss.
  
• In re K-Dur Antitrust Litigation (D. N.J.) – Served as resolution counsel in successful settlement of reverse payment class action.
• Philadelphia Taxi Association v. Uber, (E.D. Pa) – Obtained Rule 12 dismissal of Section 2 attempted monopolization claim arising out of alleged violations of taxi regulations.
• DiMartino v. BMW North American (D. N.J.) – Achieved dismissal on the pleadings of Section 2 putative class action alleging aftermarket tying.
• Gordon v. Travelport (S.D.N.Y.) – Obtained dismissal of damages claims brought by a putative class of indirect purchasers alleging collusion among global distribution systems to impose contractual restrictions on airlines.
• Willow Creek Fuels v. Buckeye Partners (E.D. Pa.) – Obtained dismissal at the pleadings stage of Section 1 and 2 Sherman Act claims, as well as Clayton Act Section 3 exclusive dealing claims brought against Buckeye by a terminated fuel distributor.
• Network Visual Services v. ARAMARK Sports and Entertainment (C.D. Cal.) – Obtained Rule 12 dismissal of Section 1 and 2 claims arising out of an alleged exclusive agreement to provide closed circuit advertising services at the Las Vegas Convention Center.
• POP Diesel Fuel Systems v. ASTM (D.N.M.) – Obtained denial of a motion for preliminary injunction and complete dismissal of Section 1 Sherman Act claim brought against a standard development organization by a producer of triglyceride fuel.
• Caltex Plastics Inc. v. Berry Plastics (C.D. Cal.) – Successfully defended a manufacturer of military specification plastic sheeting against secondary-line Robinson-Patman Act claim.
• Advanced Technology Corporation v. ASTM (D. Mass.) – Obtained with prejudice dismissal of a Sherman Act Section 1 claim brought against a standard development organization by a supplier of metal testing equipment.
• Deborah Heart & Lung Center v. University of Pennsylvania Health System (D.N.J.) – Successfully resolved claims under Sections 1 and 2 of the Sherman Act against a leading hospital system arising out of supposedly exclusive agreement pertaining to advanced cardiac services.

Brendan’s current litigation matters include:

• Defending national health insurance company in connection with antitrust claims related to the treatment of Lyme Disease.
• Defending leading manufacturer of helicopter helmets in connection with monopolization and business tort claims.
• Defending a leading vaccine manufacturer against putative class action alleging Sherman Act Section 2 violations and related state law claims.